P211 Phase 2 neoadjuvant trial: myocet (M), cyclophosphamide (C) +/− trastuzumab (T) and paclitaxel (P) +/− T
| Autor: | Pistilli, B., Benedetti, G., Rossi, D., Baldelli, A.M., Magalotti, C., Casadei, V., Foghini, L., Staffolani, M., Fiorentini, G., Latini, L. |
|---|---|
| Zdroj: | In The Breast March 2015 24 Supplement 1:S98-S98 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect